These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 832449)

  • 1. Plasma adriamycin and daunorubicin levels by fluorescence and radioimmunoassay.
    Bachur NR; Riggs CE; Green MR; Langone JJ; Van Vunakis H; Levine L
    Clin Pharmacol Ther; 1977 Jan; 21(1):70-7. PubMed ID: 832449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: plasma levels in DBA2 mice.
    Baurain R; Deprez-De Campeneere D; Trouet A
    Cancer Chemother Pharmacol; 1979; 2(1):11-4. PubMed ID: 498412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.
    Andrews PA; Brenner DE; Chou FT; Kubo H; Bachur NR
    Drug Metab Dispos; 1980; 8(3):152-6. PubMed ID: 6104578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoassays for adriamycin and daunomycin.
    Van Vunakis H; Langone JJ; Riceberg LJ; Levine L
    Cancer Res; 1974 Oct; 34(10):2546-52. PubMed ID: 4213344
    [No Abstract]   [Full Text] [Related]  

  • 6. Rapid quantitative determination of doxorubicin and its metabolites in biological samples.
    Sqalli A; Labat C; Oustrin J; Houin G; Coulais Y; Bugat R; Carton P
    Ann Biol Clin (Paris); 1989; 47(2):63-6. PubMed ID: 2735565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of adriamycin and daunorubicin-handling of blood and plasma samples.
    Eksborg S; Ehrsson H; Wallin I; Lindfors A
    Acta Pharm Suec; 1981; 18(4):215-20. PubMed ID: 7315366
    [No Abstract]   [Full Text] [Related]  

  • 8. A simplified method for determination of daunorubicin, adriamycin, and their chief fluorescent metabolites in human plasma by high-pressure liquid chromatography.
    Bolanowska W; Gessner T; Preisler H
    Cancer Chemother Pharmacol; 1983; 10(3):187-91. PubMed ID: 6574828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors.
    Formelli F; Casazza AM; Di Marco A; Mariani A; Pollini C
    Cancer Chemother Pharmacol; 1979; 3(4):261-9. PubMed ID: 294954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in adriamycin efficacy by phenobarbital.
    Reich SD; Bachur NR
    Cancer Res; 1976 Oct; 36(10):3803-6. PubMed ID: 954004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential adriamycin distribution to blood components.
    Colombo T; Broggini M; Garattini S; Donelli MG
    Eur J Drug Metab Pharmacokinet; 1981; 6(2):115-22. PubMed ID: 7274305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function.
    Benjamin RS; Riggs CE; Bachur NR
    Cancer Res; 1977 May; 37(5):1416-20. PubMed ID: 856462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations.
    Davis HL; Davis TE
    Cancer Treat Rep; 1979 May; 63(5):809-15. PubMed ID: 378369
    [No Abstract]   [Full Text] [Related]  

  • 14. A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol.
    Erb N; Erttmann R; Landbeck G
    Cancer Chemother Pharmacol; 1986; 17(1):53-5. PubMed ID: 3698178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
    Schwartz HS; Grindey GB
    Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma and urinary levels of adriamycin in man.
    Rosso R; Ravazzoni C; Esposito M; Sala R; Santi L
    Eur J Cancer (1965); 1972 Aug; 8(4):455-9. PubMed ID: 5073307
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of daunorubicin (NSC-83142) with adriamycin (NSC-123127) in the treatment of late-stage childhood solid tumors.
    Evans AE; Baehner RL; Chard RL; Leikin SL; Pang EM; Pierce M
    Cancer Chemother Rep; 1974; 58(5 Pt 1):671-6. PubMed ID: 4371948
    [No Abstract]   [Full Text] [Related]  

  • 18. Anthracycline assay by high-pressure liquid chromatography.
    Averbuch SD; Finkelstein TT; Fandrich SE; Reich SD
    J Pharm Sci; 1981 Mar; 70(3):265-9. PubMed ID: 6943332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with adriamycin and streptozotocin. II. Clincopharmacologic correlation of augmented adriamycin toxicity caused by streptozotocin.
    Chang P; Riggs CE; Scheerer MT; Wiernik PH; Bachur NR
    Clin Pharmacol Ther; 1976 Nov; 20(5):611-6. PubMed ID: 135667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of LC method for the quantification of doxorubicin in plasma and urine samples in view of pharmacokinetic, biomedical and drug monitoring therapy studies.
    Maliszewska O; Plenis A; Olędzka I; Kowalski P; Miękus N; Bień E; Krawczyk MA; Adamkiewicz-Drożynska E; Bączek T
    J Pharm Biomed Anal; 2018 Sep; 158():376-385. PubMed ID: 29936377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.